CHANDRA BHAGAT PHARMA LIMITED

Scale -

Revenue is 116 Rs Cr; Annual Growth is 31 %
Ebitda is 7.21 Rs Cr; Annual Growth is 77 %; 5 Year CAGR is 14 %
PBT is N/A Rs Cr; Annual Growth is 251 %; 5 Year CAGR is 39 %
PAT is 3.05 Rs Cr; Annual Growth is 255 %; 5 Year CAGR is 40 %

Profitability -

PBDIT Margin is 6.19 %; Annual Growth is 35 %; Continuous Growth over 3 years
PAT Margin is 2.61 %; Annual Growth is 172 %; Continuous Growth over 3 years; 5 Year CAGR is 33 %

Return -

ROCE is 17.09 %; Annual Growth is 77 %
ROA is 3.23 %; Annual Growth is 285 %; 5 Year CAGR is 31 %
ROE is 9.19 %; Annual Growth is 221 %; 5 Year CAGR is 33 %
Asset Turnover is 119 %; Annual Growth is 37 %; in Top Quartile

Efficiency -

Inventory Turnover Ratio is 43.35; Annual Growth is 129 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 399 %
Operating cash flow is 9.24 Rs Cr; Annual Growth is 266 %; in Top Quartile
Current Ratio is 1.5; Continuous Growth over 3 years
Quick Ratio is 1.42; Continuous Growth over 3 years

Solvancy -

Long term Debt is 2.57 Rs Cr; Continuous Growth over 3 years
Contingent Liabilities is 0 Rs Cr; in Top Quartile

Quality -

Operating cashflow/ebitda is 128 %; Annual Growth is 193 %; in Top Quartile; 5 Year CAGR is -18 %
Operating cashflow/PAT is 303 %; Annual Growth is 147 %; in Top Quartile; 5 Year CAGR is -34 %
Change in Inventories/Total Expenses is -3 %; Annual Decline is -134 %; in Bottom Quartile

Other Expenses/Total Expenses is 14 %; Continuous Growth over 3 years
Exceptional Items/PBT is 0 %; in Top Quartile
Current Tax/PAT is 38 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: